Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Gastric Cancer

Free Subscription Articles published in J Surg Oncol Retrieve available abstracts of 95 articles: HTML format

Single Articles

July 2024
1. CASS SH, Williams LA, Rajaram R, Hirata Y, et al
   Patient-reported outcome measures in surgical patients with upper gastrointestinal cancers: A qualitative interview study.
   J Surg Oncol. 2024;130:117-124.
   PubMed     Abstract available
   
   
   June 2024
2. DA SILVA LM, Martins MR, Dos Santos RL, Da Silva JPA, et al
   Evaluation of soluble co-inhibitors and co-stimulators levels of the immune response in gastric cancer.
   J Surg Oncol. 2024 Jun 30. doi: 10.1002/jso.27747.
   PubMed     Abstract available
   
   
   
3. SOUZA WP, Pereira MA, Cardili L, Zilberstein B, et al
   Evaluation of the endoscopic cure criteria in patients undergoing surgery for early gastric cancer.
   J Surg Oncol. 2024 Jun 27. doi: 10.1002/jso.27745.
   PubMed     Abstract available
   
   
   
4. JANCZEWSKI LM, Buchheit J, Jacobs RC, Vitello D, et al
   Utilization and survival outcomes of neoadjuvant chemotherapy for early-stage gastric cancer.
   J Surg Oncol. 2024 Jun 17. doi: 10.1002/jso.27732.
   PubMed     Abstract available
   
   
   May 2024
5. JANCZEWSKI LM, Bentrem DJ, Chawla A
   Response to comment on: "Comparison of perioperative and histopathologic outcomes among neoadjuvant treatment strategies for locoregional gastric cancer".
   J Surg Oncol. 2024 May 27. doi: 10.1002/jso.27678.
   PubMed    
   
   
   
6. DA COSTA WL JR,, Tan MC, Camp ER, Thrift AP, et al
   Patient- and system-level factors associated with racial/ethnic disparities in the delivery of guideline-concordant therapy among US patients with gastric cancer.
   J Surg Oncol. 2024 May 16. doi: 10.1002/jso.27683.
   PubMed     Abstract available
   
   
   
7. CORSO G, Davis JL, Strong VE
   Points to consider regarding prophylactic total gastrectomy in germline CDH1 variant carriers.
   J Surg Oncol. 2024;129:1082-1088.
   PubMed     Abstract available
   
   
   April 2024
8. LI C, Qu M, Ye Y, Zhu F, et al
   Letter to the Editor: Comment on: "Comparison of perioperative and histopathologic outcomes among neoadjuvant treatment strategies for locoregional gastric cancer".
   J Surg Oncol. 2024 Apr 29. doi: 10.1002/jso.27667.
   PubMed    
   
   
   
9. DIAS AR, Pereira MA, Ramos MFKP, de Oliveira RJ, et al
   Robotic versus laparoscopic gastrectomy for gastric cancer: A Western propensity score matched analysis.
   J Surg Oncol. 2024 Apr 17. doi: 10.1002/jso.27651.
   PubMed     Abstract available
   
   
   March 2024
10. NAQVI A, Matias N, Al-Khaffaf B
    Reporting of core outcomes in gastric cancer surgery trials over the past 25 years (systematic review).
    J Surg Oncol. 2024 Mar 6. doi: 10.1002/jso.27613.
    PubMed     Abstract available
    
    
    
11. KIM JY, Love M, Woo Y, Campos B, et al
    Pilot study of a telehealth intervention for personalized self-management for eating symptoms after gastroesophageal cancer surgery.
    J Surg Oncol. 2024;129:728-733.
    PubMed     Abstract available
    
    
    February 2024
12. LILLEY EJ, Lu P, Robinson K, Griffith H, et al
    High symptom burden in patients undergoing gastrectomy for cancer.
    J Surg Oncol. 2024;129:228-232.
    PubMed     Abstract available
    
    
    January 2024
13. HONDO N, Yamamoto Y, Nakabe T, Otsubo T, et al
    Short-term outcomes of laparoscopic and robotic distal gastrectomy for gastric cancer: Real-world evidence from a large-scale inpatient database in Japan.
    J Surg Oncol. 2024 Jan 4. doi: 10.1002/jso.27575.
    PubMed     Abstract available
    
    
    
14. VAN DER WIELEN N, Brenkman H, Seesing M, Daams F, et al
    Minimally invasive versus open gastrectomy for gastric cancer. A pooled analysis of two European randomized controlled trials.
    J Surg Oncol. 2024 Jan 4. doi: 10.1002/jso.27578.
    PubMed     Abstract available
    
    
    
15. SESTITO M, Pratt H, Schmidt C, Thomay A, et al
    Recent advances for treatment of upper gastrointestinal malignancy.
    J Surg Oncol. 2024;129:48-62.
    PubMed     Abstract available
    
    
    December 2023
16. CASPERS IA, Slagter AE, Lind P, Sikorska K, et al
    The impact of sex on treatment and outcome in relation to histological subtype in patients with resectable gastric cancer: Results from the randomized CRITICS trial.
    J Surg Oncol. 2023 Dec 10. doi: 10.1002/jso.27554.
    PubMed     Abstract available
    
    
    
17. KARALIS JD, Ju MR, Feig R, Estrella R, et al
    Intensifying supportive care is associated with improved survival in gastric cancer patients with malignant ascites.
    J Surg Oncol. 2023 Dec 8. doi: 10.1002/jso.27556.
    PubMed     Abstract available
    
    
    November 2023
18. JANCZEWSKI LM, Logan CD, Vitello DJ, Buchheit JT, et al
    Comparison of perioperative and histopathologic outcomes among neoadjuvant treatment strategies for locoregional gastric cancer.
    J Surg Oncol. 2023 Nov 20. doi: 10.1002/jso.27521.
    PubMed     Abstract available
    
    
    October 2023
19. MAVANI PT, Ajay PS, Goyal S, Shah MM, et al
    Reply to: Striking a balance: Deciphering the dilemma of treatment equivalence in cardia gastric cancer.
    J Surg Oncol. 2023 Oct 17. doi: 10.1002/jso.27483.
    PubMed    
    
    
    
20. LOUAFI MO, Lahnaoui O, Benkabbou A, Majbar MA, et al
    Striking a balance: Deciphering the dilemma of treatment equivalence in cardia gastric cancer.
    J Surg Oncol. 2023 Oct 16. doi: 10.1002/jso.27452.
    PubMed    
    
    
    June 2023
21. JANCZEWSKI LM, Shah D, Wells A, Bentrem DJ, et al
    The inaccuracies of gastric adenocarcinoma clinical staging and its predictive factors.
    J Surg Oncol. 2023;127:1116-1124.
    PubMed     Abstract available
    
    
    April 2023
22. AJAY PS, Sok CP, Goyal S, Switchenko JM, et al
    Impact of nodal status in determining multimodal treatment strategies in non-cardia gastric cancer.
    J Surg Oncol. 2023 Apr 28. doi: 10.1002/jso.27297.
    PubMed     Abstract available
    
    
    
23. AJAY PS, NeMoyer R, Goyal S, Switchenko JM, et al
    Does non-metastatic gastric cancer of the cardia warrant a different treatment strategy?
    J Surg Oncol. 2023 Apr 10. doi: 10.1002/jso.27276.
    PubMed     Abstract available
    
    
    February 2023
24. AYLOOR SESHADRI R, Soman AC, Aggrawal A, Karnawat A, et al
    Conditional survival in patients treated for gastric cancer with a curative intent.
    J Surg Oncol. 2023 Feb 3. doi: 10.1002/jso.27209.
    PubMed     Abstract available
    
    
    January 2023
25. MARKOPOULOS GS, Vartholomatos G, Alexiou GAlpha, Tatsis V, et al
    Resection margin status evaluation in gastric cancer surgery by intraoperative flow cytometry.
    J Surg Oncol. 2023 Jan 4. doi: 10.1002/jso.27187.
    PubMed    
    
    
    December 2022
26. WATANABE A, McKendry GJ, Yip L, Donnellan F, et al
    Risk of lymph node metastasis in early gastric cancer for a Western population.
    J Surg Oncol. 2022 Dec 30. doi: 10.1002/jso.27192.
    PubMed     Abstract available
    
    
    
27. YANG XY, Zhu K, Hu Q
    The order of surgery and chemotherapy matters: Multimodality therapy and stage-specific differences in survival in gastric cancer.
    J Surg Oncol. 2022 Dec 7. doi: 10.1002/jso.27158.
    PubMed    
    
    
    
28. STILLMAN MD, Kusche N, Toledano S, Hilfrank KJ, et al
    Short and long-term outcomes of prophylactic total gastrectomy in 54 consecutive individuals with germline pathogenic mutations in the CDH1 gene.
    J Surg Oncol. 2022;126:1413-1422.
    PubMed     Abstract available
    
    
    
29. WU L, Xing Z, Huang M, Yu H, et al
    Nodal downstaging to ypN0 after neoadjuvant chemotherapy positively impacts on survival of cT4N+ GC/GEJ patients.
    J Surg Oncol. 2022;126:1403-1412.
    PubMed     Abstract available
    
    
    October 2022
30. RAMOS-SANTILLAN V, Friedmann P, Eskander M, Chuy J, et al
    The order of surgery and chemotherapy matters: Multimodality therapy and stage-specific differences in survival in gastric cancer.
    J Surg Oncol. 2022 Oct 4. doi: 10.1002/jso.27110.
    PubMed     Abstract available
    
    
    
31. COIT DG, Strong VE
    Fifty years of progress in gastric cancer.
    J Surg Oncol. 2022;126:865-871.
    PubMed     Abstract available
    
    
    September 2022
32. WATANABE A, Adamson H, Lim H, McFadden AF, et al
    Intraoperative frozen section analysis of margin status as a quality indicator in gastric cancer surgery.
    J Surg Oncol. 2022 Sep 30. doi: 10.1002/jso.27107.
    PubMed     Abstract available
    
    
    
33. VAN KOOTEN RT, Bahadoer RR, Ter Buurkes de Vries B, Wouters MWJM, et al
    Conventional regression analysis and machine learning in prediction of anastomotic leakage and pulmonary complications after esophagogastric cancer surgery.
    J Surg Oncol. 2022;126:490-501.
    PubMed     Abstract available
    
    
    
34. LEDER MACEK AJ, Wang A, Turgeon MK, Lee RM, et al
    Diagnostic laparoscopy is underutilized in the staging of gastric adenocarcinoma regardless of hospital type: An US safety net collaborative analysis.
    J Surg Oncol. 2022;126:649-657.
    PubMed     Abstract available
    
    
    August 2022
35. STILLMAN MD, Yoon SS
    Open and minimally invasive gastrectomy in Eastern and Western patient populations: A review of the literature and reasons for differences in outcomes.
    J Surg Oncol. 2022;126:279-291.
    PubMed     Abstract available
    
    
    July 2022
36. RUGGE M, Genta RM
    Gastric cancer prevention: Merging future hopes, with present clinical practice.
    J Surg Oncol. 2022 Jul 19. doi: 10.1002/jso.26997.
    PubMed    
    
    
    
37. DA COSTA WL, Tran Cao HS, Gu X, Massarweh NN, et al
    Understanding the association between clinical staging accuracy, treatment response, and survival among gastric cancer patients through Bayesian analysis.
    J Surg Oncol. 2022 Jul 12. doi: 10.1002/jso.27016.
    PubMed     Abstract available
    
    
    
38. RIBEIRO HSC, Menezes JN, da Costa WL Jr, F de Jesus VH, et al
    PD-L1 expression in gastric and gastroesophageal junction cancer patients treated with perioperative chemotherapy.
    J Surg Oncol. 2022;126:150-160.
    PubMed     Abstract available
    
    
    
39. DA SILVA JPA, Martins MR, Dos Santos RL, da Silva LM, et al
    Evaluation of platelet activation marker expression and its correlation with tumorigenesis and tumor progression in patients with gastric cancer.
    J Surg Oncol. 2022;126:125-131.
    PubMed     Abstract available
    
    
    
40. DIAS AR, Pereira MA, Ramos MFKP, Barchi LC, et al
    Gastrectomy for elderly gastric cancer patients: A propensity score-matching analysis.
    J Surg Oncol. 2022;126:108-115.
    PubMed     Abstract available
    
    
    
41. DIAS AR, Pereira MA, Ramos MFKP, Ribeiro U Jr, et al
    Preoperative chemotherapy is a better strategy than upfront surgery in cT4 gastric cancer.
    J Surg Oncol. 2022;126:132-138.
    PubMed     Abstract available
    
    
    
42. DIAS AR, Pereira MA, Ramos MFKP, Ribeiro U Jr, et al
    Multivisceral resection compared to standard gastrectomy for gastric adenocarcinoma: A propensity score-matching analysis.
    J Surg Oncol. 2022;126:99-107.
    PubMed     Abstract available
    
    
    
43. PEREIRA MA, Dias AR, Ramos MFKP, Cardili L, et al
    Gastric cancer with microsatellite instability displays increased thymidylate synthase expression.
    J Surg Oncol. 2022;126:116-124.
    PubMed     Abstract available
    
    
    
44. LIMA CAC, da Silva LM, Dos Santos RL, Silva JPA, et al
    Unbalanced expression of sICOS and sPD-1 correlates with tumor progression in gastric cancer.
    J Surg Oncol. 2022;126:144-149.
    PubMed     Abstract available
    
    
    
45. LIMA CAC, Martins MR, Dos Santos RL, da Silva LM, et al
    High soluble OX40 levels correlate with metastatic gastric cancer.
    J Surg Oncol. 2022;126:139-143.
    PubMed     Abstract available
    
    
    
46. SOUADKA A, Essangri H, Elazzaoui F, Majbar MA, et al
    Staging laparoscopy in locally advanced gastric cancer: Beware the poorly differentiated histological subtype.
    J Surg Oncol. 2022 Jul 1. doi: 10.1002/jso.26966.
    PubMed    
    
    
    June 2022
47. SHAH D, Bentrem D
    Environmental and genetic risk factors for gastric cancer.
    J Surg Oncol. 2022;125:1096-1103.
    PubMed     Abstract available
    
    
    
48. MESCI A, Wong RK
    Current and future strategies for radiation therapy in gastric cancer.
    J Surg Oncol. 2022;125:1161-1175.
    PubMed     Abstract available
    
    
    
49. SCHMIDT CR
    Innovations defining the future of gastric cancer-Introduction.
    J Surg Oncol. 2022;125:1077-1078.
    PubMed    
    
    
    
50. ENGEL D, Saric S, Minnella E, Carli F, et al
    Strategies for optimal perioperative outcomes in gastric cancer.
    J Surg Oncol. 2022;125:1135-1141.
    PubMed     Abstract available
    
    
    
51. SCHMIDT CR
    Innovations defining the future of gastric cancer: Summary.
    J Surg Oncol. 2022;125:1183.
    PubMed    
    
    
    
52. ORTIGAO R, Libanio D, Dinis-Ribeiro M
    The future of endoscopic resection for early gastric cancer.
    J Surg Oncol. 2022;125:1110-1122.
    PubMed     Abstract available
    
    
    
53. KHAN H, Johnston FM
    Current role for cytoreduction and HIPEC for gastric cancer with peritoneal disease.
    J Surg Oncol. 2022;125:1176-1182.
    PubMed     Abstract available
    
    
    
54. THAM E, Sestito M, Markovich B, Garland-Kledzik M, et al
    Current and future imaging modalities in gastric cancer.
    J Surg Oncol. 2022;125:1123-1134.
    PubMed     Abstract available
    
    
    
55. CHOI S, Hyung WJ
    Modern surgical therapy for gastric cancer-Robotics and beyond.
    J Surg Oncol. 2022;125:1142-1150.
    PubMed     Abstract available
    
    
    
56. XIA JY, Aadam AA
    Advances in screening and detection of gastric cancer.
    J Surg Oncol. 2022;125:1104-1109.
    PubMed     Abstract available
    
    
    
57. IVEY A, Pratt H, Boone BA
    Molecular pathogenesis and emerging targets of gastric adenocarcinoma.
    J Surg Oncol. 2022;125:1079-1095.
    PubMed     Abstract available
    
    
    
58. CORSO G
    Pleiotropic cancer manifestations of germline CDH1 mutations: Risks and management.
    J Surg Oncol. 2022;125:1326-1331.
    PubMed     Abstract available
    
    
    
59. BRACALE U, Peltrini R, Corcione F
    "Impact of neoadjuvant therapy followed by laparoscopic radical gastrectomy with D2 lymph node dissection in Western population: A multi-institutional propensity score matched study"-Authors' reply.
    J Surg Oncol. 2022;125:1338-1339.
    PubMed    
    
    
    April 2022
60. KASLOW SR, Ma Z, Hani L, Prendergast K, et al
    Adherence to guidelines at the patient- and hospital-levels is associated with improved overall survival in patients with gastric cancer.
    J Surg Oncol. 2022 Apr 26. doi: 10.1002/jso.26895.
    PubMed     Abstract available
    
    
    March 2022
61. SPOLVERATO G, Paro A, Capelli G, Dalmacy D, et al
    Surgical treatment of gastric adenocarcinoma: Are we achieving textbook oncologic outcomes for our patients?
    J Surg Oncol. 2022;125:621-630.
    PubMed     Abstract available
    
    
    
62. CANN C, Ciombor KK
    Systemic therapy for gastric cancer: Perioperative strategies and beyond.
    J Surg Oncol. 2022 Mar 1. doi: 10.1002/jso.26834.
    PubMed     Abstract available
    
    
    January 2022
63. KOBAYASHI H, Honda M, Kawamura H, Takiguchi K, et al
    Clinical impact of gastrectomy for gastric cancer patients with positive lavage cytology without gross peritoneal dissemination.
    J Surg Oncol. 2022 Jan 5. doi: 10.1002/jso.26770.
    PubMed     Abstract available
    
    
    
64. BADGWELL B
    Regional therapy trials in peritoneal metastases: The path to standardization of care for gastric cancer.
    J Surg Oncol. 2022;125:64-68.
    PubMed     Abstract available
    
    
    December 2021
65. VAN WINSEN M, McSorley ST, McLeod R, MacDonald A, et al
    Postoperative C-reactive protein concentrations to predict infective complications following gastrectomy for cancer.
    J Surg Oncol. 2021;124:1060-1069.
    PubMed     Abstract available
    
    
    
66. LI Z, Wang Y, Ying X, Zhang L, et al
    Prognostic and predictive value of mismatch repair deficiency in gastric and gastroesophageal junction adenocarcinoma patients receiving neoadjuvant or adjuvant chemotherapy.
    J Surg Oncol. 2021;124:1356-1364.
    PubMed     Abstract available
    
    
    
67. WANG Y, Liu Z, Shan F, Ying X, et al
    Short-term outcomes after totally laparoscopic total gastrectomy with esophagojejunostomy constructed by pi-shaped method versus overlap method.
    J Surg Oncol. 2021;124:1329-1337.
    PubMed     Abstract available
    
    
    
68. BRACALE U, Corcione F, Pignata G, Andreuccetti J, et al
    Impact of neoadjuvant therapy followed by laparoscopic radical gastrectomy with D2 lymph node dissection in Western population: A multi-institutional propensity score-matched study.
    J Surg Oncol. 2021;124:1338-1346.
    PubMed     Abstract available
    
    
    
69. KRONENFELD JP, Collier AL, Turgeon MK, Ju M, et al
    Attrition during neoadjuvant chemotherapy for gastric adenocarcinoma is associated with decreased survival: A United States Safety-Net Collaborative analysis.
    J Surg Oncol. 2021;124:1317-1328.
    PubMed     Abstract available
    
    
    November 2021
70. HU Q, Chen J, Sun Y
    Comment on "Staged laparoscopic management of locally advanced gastric cancer with outlet obstruction".
    J Surg Oncol. 2021 Nov 17. doi: 10.1002/jso.26560.
    PubMed    
    
    
    
71. HU Q, Sun J, Zhu KF
    Postoperative C-reactive protein concentrations to predict infective complications of gastric cancer.
    J Surg Oncol. 2021 Nov 17. doi: 10.1002/jso.26649.
    PubMed    
    
    
    
72. HU Q, Sun J
    Perioperative-enhanced recovery protocol in patients undergoing open gastrectomy for gastric cancer.
    J Surg Oncol. 2021 Nov 17. doi: 10.1002/jso.26630.
    PubMed    
    
    
    September 2021
73. KIM J, Han SH, Kim HI
    Detection of sarcopenic obesity and prediction of long-term survival in patients with gastric cancer using preoperative computed tomography and machine learning.
    J Surg Oncol. 2021 Sep 7. doi: 10.1002/jso.26668.
    PubMed     Abstract available
    
    
    August 2021
74. WEST MA, Baker WC, Rahman S, Munro A, et al
    Cardiopulmonary exercise testing has greater prognostic value than sarcopenia in oesophago-gastric cancer patients undergoing neoadjuvant therapy and surgical resection.
    J Surg Oncol. 2021 Aug 31. doi: 10.1002/jso.26652.
    PubMed     Abstract available
    
    
    July 2021
75. KARALIS JD, Ju MR, Mansour JC, Polanco PM, et al
    The presentation of Hispanic gastric cancer patients varies by location of patient ancestry.
    J Surg Oncol. 2021 Jul 15. doi: 10.1002/jso.26609.
    PubMed     Abstract available
    
    
    
76. PEREIRA MA, de Castria TB, Ramos MFKP, Dias AR, et al
    Cytotoxic T-lymphocyte-associated protein 4 in gastric cancer: Prognosis and association with PD-L1 expression.
    J Surg Oncol. 2021 Jul 13. doi: 10.1002/jso.26604.
    PubMed     Abstract available
    
    
    
77. BLUMENTHALER AN, Robinson KA, Kruse BC, Munder K, et al
    Implementation of a perioperative-enhanced recovery protocol in patients undergoing open gastrectomy for gastric cancer.
    J Surg Oncol. 2021 Jul 6. doi: 10.1002/jso.26591.
    PubMed     Abstract available
    
    
    
78. APTE SS, Radonjic A, Wong B, Dingley B, et al
    Preoperative imaging of gastric GISTs underestimates pathologic tumor size: A retrospective, single institution analysis.
    J Surg Oncol. 2021;124:49-58.
    PubMed     Abstract available
    
    
    
79. DU J, Xue H, Zhao L, Zhang Z, et al
    Handover method: Simple, classic and harmonized intracorporeal closure of stapled duodenal stump during laparoscopic gastrectomy.
    J Surg Oncol. 2021;124:41-48.
    PubMed    
    
    
    June 2021
80. TURGEON MK, Lee RM, Keilson JM, Ju MR, et al
    Is there a difference in utilization of a perioperative treatment approach for gastric cancer between safety net hospitals and tertiary referral centers?
    J Surg Oncol. 2021 Jun 1. doi: 10.1002/jso.26554.
    PubMed     Abstract available
    
    
    
81. RAO T S, Raju KVVN, Patnaik SC, Reddy P, et al
    Influence of neoadjuvant therapy on outcomes in patients with resectable carcinoma of esophagus and gastro-esophageal junction from a tertiary cancer care center in India.
    J Surg Oncol. 2021;123:1547-1557.
    PubMed     Abstract available
    
    
    May 2021
82. ITAI Y, Ueda Y, Etoh T, Shirasaka Y, et al
    Clinical significance of sarcoid-like reaction in lymph nodes of gastric cancer patients.
    J Surg Oncol. 2021 May 18. doi: 10.1002/jso.26525.
    PubMed     Abstract available
    
    
    
83. HONG J, Wang YP, Wang J, Hua LC, et al
    The safety and feasibility of intra-corporeal gastroduodenostomy using a self-pulling and latter transected method (Delta SPLT) in totally laparoscopic distal gastrectomy.
    J Surg Oncol. 2021;123 Suppl 1:S25-S29.
    PubMed     Abstract available
    
    
    
84. CAI Z, Ma J, Li S, Fingerhut A, et al
    Impact of microsatellite status on negative lymph node count and prognostic relevance after curative gastrectomy.
    J Surg Oncol. 2021;123 Suppl 1:S15-S24.
    PubMed     Abstract available
    
    
    April 2021
85. LIN JX, Huang YQ, Wang ZK, Xie JW, et al
    Prognostic importance of dynamic changes in systemic inflammatory markers for patients with gastric cancer.
    J Surg Oncol. 2021 Apr 29. doi: 10.1002/jso.26498.
    PubMed     Abstract available
    
    
    
86. ZHANG LY, Ma JJ, Zang L, Hong HJ, et al
    Staged laparoscopic management of locally advanced gastric cancer with outlet obstruction.
    J Surg Oncol. 2021 Apr 5. doi: 10.1002/jso.26342.
    PubMed     Abstract available
    
    
    March 2021
87. LIU J, Li H, Zhou P, Cai T, et al
    Reevaluation of lymphovascular invasion in gastric cancer using endothelial markers D2-40 and EVG: Enhanced detection, better predictor of lymph node metastasis and biological aggressiveness.
    J Surg Oncol. 2021 Mar 26. doi: 10.1002/jso.26468.
    PubMed     Abstract available
    
    
    
88. RAJABNEJAD A, Vaida F, Valasek M, Razzaque S, et al
    Predictors and significance of histologic response to neoadjuvant therapy for gastric cancer.
    J Surg Oncol. 2021 Mar 18. doi: 10.1002/jso.26458.
    PubMed     Abstract available
    
    
    
89. PORTUONDO JI, Tran Cao HS, da Costa WL, Sada YH, et al
    Treatment approach, hospital practice patterns, and receipt of multimodality therapy as measures of quality for locally advanced gastric cancer.
    J Surg Oncol. 2021 Mar 15. doi: 10.1002/jso.26460.
    PubMed     Abstract available
    
    
    
90. WU T, Wang CH, Wang W, Liu LL, et al
    Association of preoperative and postoperative CA72-4 with gastric cancer outcome.
    J Surg Oncol. 2021 Mar 8. doi: 10.1002/jso.26446.
    PubMed     Abstract available
    
    
    
91. WEI Q, Xu Q, Yuan X, Li JJ, et al
    Immunological impact of chemotherapy on the tumor microenvironment in gastric cancer.
    J Surg Oncol. 2021 Mar 8. doi: 10.1002/jso.26449.
    PubMed     Abstract available
    
    
    
92. KOEMANS WJ, van der Kaaij RT, Wassenaar ECE, Boerma D, et al
    Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial.
    J Surg Oncol. 2021;123:904-910.
    PubMed     Abstract available
    
    
    
93. BLUMENTHALER AN, Newhook TE, Ikoma N, Estrella JS, et al
    Concurrent lymphovascular and perineural invasion after preoperative therapy for gastric adenocarcinoma is associated with decreased survival.
    J Surg Oncol. 2021;123:911-922.
    PubMed     Abstract available
    
    
    January 2021
94. LOMBARDI PM, Mazzola M, Achilli P, Aquilano MC, et al
    Prognostic value of pathological tumor regression grade in locally advanced gastric cancer: New perspectives from a single-center experience.
    J Surg Oncol. 2021 Jan 26. doi: 10.1002/jso.26391.
    PubMed     Abstract available
    
    
    December 2020
95. PANDURO-CORREA V, Cubas WS, Herrera-Matta JJ, Maguina JL, et al
    Survival and adequate preoperative staging in patients undergoing gastric cancer surgery at a Peruvian Police Hospital.
    J Surg Oncol. 2020 Dec 1. doi: 10.1002/jso.26315.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.